How can we improve the assessment of safety in child and adolescent psychopharmacology?

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 42, Issue 6, 2003, Pages 634-641

  Vitiello, Benedetto ^a   Riddle, Mark A ^b   Greenhill, Laurence L ^c   March, John S ^d   Levine, Jerome ^e   Schachar, Russell J ^f   Abikoff, Howard ^g   Zito, Julie M ^h   McCracken, James T ⁱ   Walkup, John T ^b   Findling, Robert L ^j   Robinson, James ^e   Cooper, Thomas B ^e   Davies, Mark ^c   Varipatis, Elena ^b   Labellarte, Michael J ^b   Scahill, Lawrence ^k   Capasso, Lisa ^c  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e Nathan Kline Institute   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

^g NEW YORK UNIVERSITY   (United States)

^h UNIVERSITY OF MARYLAND   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j CASE WESTERN RESERVE UNIVERSITY   (United States)

^k YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Adverse events; Children; Psychopharmacology; Treatment

Indexed keywords

PSYCHOTROPIC AGENT;

ADOLESCENT; CASE CONTROL STUDY; CHILD; COHORT ANALYSIS; DRUG SAFETY; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; HUMAN; METHODOLOGY; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REVIEW; RISK ASSESSMENT; SIDE EFFECT; STANDARDIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG SURVEILLANCE PROGRAM; FEMALE; MALE; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; STANDARD;

ADOLESCENT; ADVERSE DRUG REACTION REPORTING SYSTEMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; PSYCHOPHARMACOLOGY; PSYCHOTROPIC DRUGS; RANDOMIZED CONTROLLED TRIALS;

EID: 0642281437     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CHI.0000046840.90931.36     Document Type: Article

References (3)

1. Anderson GM, Cook EH (2000), Pharmacogenetics: promise and potential in child and adolescent psychiatry. Child Adolesc Psychiatr Clin N Am 9:23-42
2. Bate A, Lindquist M, Edwards IR et al. (1998), A Bayesian neural network method for adverse event drug interacrion signal generation. Eur J Clin Pharmacol 54:315-321
3. Biederman J, Thisted R, Greenhill L, Ryan N (1995), Estimation of the association between desipramine and the risk for sudden death in 5- to 14-year-old children. J Clin Psychiatry 56:87-93